{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:21:38Z","timestamp":1781497298005,"version":"3.54.1"},"reference-count":49,"publisher":"Norwegian Medical Association","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskriftet"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4045\/tidsskr.12.0376","type":"journal-article","created":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T14:04:51Z","timestamp":1358863491000},"page":"2494-2499","source":"Crossref","is-referenced-by-count":5,"title":["Infertilitetsbehandling og kreftrisiko"],"prefix":"10.4045","volume":"132","author":[{"given":"Ritsa","family":"Storeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Vangen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Katerine","family":"Omland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan Birgitte","family":"Oldereid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"2934068_ref_1","doi-asserted-by":"crossref","unstructured":"Boivin J, Bunting L, Collins JA et al. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007; 22: 1506 - 12.","DOI":"10.1093\/humrep\/dem046"},{"key":"2934068_ref_2","unstructured":"Wright VC, Chang J, Jeng G et al. Assisted reproductive technology surveillance-United States, 2005. MMWR Surveill Summ 2008; 57: 1 - 23."},{"key":"2934068_ref_3","unstructured":"U.S.Department of Health and Human Services, National Institutes of Health. FactSheet; Menopausal hormone therapy and cancer. www.cancer.gov\/cancertopics\/factsheet\/Risk\/menopausal-hormones (10.10.2012)."},{"key":"2934068_ref_4","doi-asserted-by":"crossref","unstructured":"Farley J, Ozbun LL, Birrer MJ. Genomic analysis of epithelial ovarian cancer. Cell Res 2008; 18: 538 - 48.","DOI":"10.1038\/cr.2008.52"},{"key":"2934068_ref_5","unstructured":"Haldorsen T, red. Cancer in Norway 2009. Special issue: Cancer screening in Norway. Oslo: Kreftregisteret, 2011."},{"key":"2934068_ref_6","doi-asserted-by":"crossref","unstructured":"Calderon-Margalit R, Friedlander Y, Yanetz R et al. Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol 2009; 169: 365 - 75.","DOI":"10.1093\/aje\/kwn318"},{"key":"2934068_ref_7","doi-asserted-by":"crossref","unstructured":"Dor J, Lerner-Geva L, Rabinovici J et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002; 77: 324 - 7.","DOI":"10.1016\/S0015-0282(01)02986-7"},{"key":"2934068_ref_8","doi-asserted-by":"crossref","unstructured":"Doyle P, Maconochie N, Beral V et al. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 2002; 17: 2209 - 13.","DOI":"10.1093\/humrep\/17.8.2209"},{"key":"2934068_ref_9","doi-asserted-by":"crossref","unstructured":"Gauthier E, Paoletti X, Clavel-Chapelon F; E3N group. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod 2004; 19: 2216 - 21.","DOI":"10.1093\/humrep\/deh422"},{"key":"2934068_ref_10","doi-asserted-by":"crossref","unstructured":"Lerner-Geva L, Geva E, Lessing JB et al. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer 2003; 13: 23 - 7.","DOI":"10.1046\/j.1525-1438.2003.13041.x"},{"key":"2934068_ref_11","doi-asserted-by":"crossref","unstructured":"Liat LG, Jaron R, Liraz O et al. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. Gynecol Endocrinol 2012; 28: 809 - 14.","DOI":"10.3109\/09513590.2012.671391"},{"key":"2934068_ref_12","doi-asserted-by":"crossref","unstructured":"Rossing MA, Daling JR, Weiss NS et al. Risk of\u00a0breast cancer in a cohort of infertile women. Gynecol Oncol 1996; 60: 3 - 7.","DOI":"10.1006\/gyno.1996.0002"},{"key":"2934068_ref_13","doi-asserted-by":"crossref","unstructured":"Yli-Kuha AN, Gissler M, Klemetti R et al. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod 2012; 27: 1149 - 55.","DOI":"10.1093\/humrep\/des031"},{"key":"2934068_ref_14","doi-asserted-by":"crossref","unstructured":"K\u00e4ll\u00e9n B, Finnstr\u00f6m O, Lindam A et al. Malignancies among women who gave birth after in vitro fertilization. Hum Reprod 2011; 26: 253 - 8.","DOI":"10.1093\/humrep\/deq307"},{"key":"2934068_ref_15","doi-asserted-by":"crossref","unstructured":"Terry KL, Willett WC, Rich-Edwards JW et al. A\u00a0prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Arch Intern Med 2006; 166: 2484 - 9.","DOI":"10.1001\/archinte.166.22.2484"},{"key":"2934068_ref_16","doi-asserted-by":"crossref","unstructured":"Brinton LA, Scoccia B, Moghissi KS et al. Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 2004; 19: 2005 - 13.","DOI":"10.1093\/humrep\/deh371"},{"key":"2934068_ref_17","doi-asserted-by":"crossref","unstructured":"Jensen A, Sharif H, Svare EI et al. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidemiol Biomarkers Prev 2007; 16: 1400 - 7.","DOI":"10.1158\/1055-9965.EPI-07-0075"},{"key":"2934068_ref_18","doi-asserted-by":"crossref","unstructured":"Katz D, Paltiel O, Peretz T et al. Beginning IVF treatments after age 30 increases the risk of breast cancer: results of a case-control study. Breast J 2008; 14: 517 - 22.","DOI":"10.1111\/j.1524-4741.2008.00641.x"},{"key":"2934068_ref_19","doi-asserted-by":"crossref","unstructured":"Lerner-Geva L, Keinan-Boker L, Blumstein T et al. Infertility, ovulation induction treatments and the incidence of breast cancer-a historical prospective cohort of Israeli women. Breast Cancer Res Treat 2006; 100: 201 - 12.","DOI":"10.1007\/s10549-006-9238-4"},{"key":"2934068_ref_20","doi-asserted-by":"crossref","unstructured":"Org\u00e9as CC, Sanner K, Hall P et al. Breast cancer incidence after hormonal infertility treatment in\u00a0Sweden: a cohort study. Am J Obstet Gynecol 2009; 200: 72.e1 - 7.","DOI":"10.1016\/j.ajog.2008.08.066"},{"key":"2934068_ref_21","doi-asserted-by":"crossref","unstructured":"dos Santos Silva I, Wark PA, McCormack VA et al. Ovulation-stimulation drugs and cancer risks: a\u00a0long-term follow-up of a British cohort. Br J Cancer 2009; 100: 1824 - 31.","DOI":"10.1038\/sj.bjc.6605086"},{"key":"2934068_ref_22","first-page":"1586 - 90","volume":"354","author":"Venn A, Watson L, Bruinsma F et al","year":"Lancet","journal-title":"22"},{"key":"2934068_ref_23","doi-asserted-by":"crossref","unstructured":"Zreik TG, Mazloom A, Chen Y et al. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Res Treat 2010; 124: 13 - 26.","DOI":"10.1007\/s10549-010-1140-4"},{"key":"2934068_ref_24","doi-asserted-by":"crossref","unstructured":"Brinton LA, Lamb EJ, Moghissi KS et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 2004; 82: 405 - 14.","DOI":"10.1016\/j.fertnstert.2004.02.109"},{"key":"2934068_ref_25","doi-asserted-by":"crossref","unstructured":"Cusid\u00f3 M, F\u00e1bregas R, Pere BS et al. Ovulation induction treatment and risk of borderline ovarian tumors. Gynecol Endocrinol 2007; 23: 373 - 6.","DOI":"10.1080\/09513590701350341"},{"key":"2934068_ref_26","first-page":"b249","volume":"338","author":"Jensen A, Sharif H, Frederiksen K et al","year":"BMJ","journal-title":"26"},{"key":"2934068_ref_27","doi-asserted-by":"crossref","unstructured":"Mosgaard BJ, Lidegaard O, Kjaer SK et al. Ovarian stimulation and borderline ovarian tumors: a case-control study. Fertil Steril 1998; 70: 1049 - 55.","DOI":"10.1016\/S0015-0282(98)00337-9"},{"key":"2934068_ref_28","doi-asserted-by":"crossref","unstructured":"Rossing MA, Tang MT, Flagg EW et al. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. Am\u00a0J\u00a0 Epidemiol 2004; 160: 1070 - 8.","DOI":"10.1093\/aje\/kwh315"},{"key":"2934068_ref_29","doi-asserted-by":"crossref","unstructured":"Franceschi S, La Vecchia C, Negri E et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994; 9: 1673 - 5.","DOI":"10.1093\/oxfordjournals.humrep.a138771"},{"key":"2934068_ref_30","doi-asserted-by":"crossref","unstructured":"van Leeuwen FE, Klip H, Mooij TM et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a\u00a0large Dutch cohort. Hum Reprod 2011; 26: 3456 - 65.","DOI":"10.1093\/humrep\/der322"},{"key":"2934068_ref_31","doi-asserted-by":"crossref","unstructured":"Sanner K, Conner P, Bergfeldt K et al. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil Steril 2009; 91: 1152 - 8.","DOI":"10.1016\/j.fertnstert.2008.01.073"},{"key":"2934068_ref_32","doi-asserted-by":"crossref","unstructured":"Rossing MA, Daling JR, Weiss NS et al. Ovarian tumors in a cohort of infertile women. N Engl J\u00a0Med 1994; 331: 771 - 6.","DOI":"10.1056\/NEJM199409223311204"},{"key":"2934068_ref_33","doi-asserted-by":"crossref","unstructured":"Shushan A, Paltiel O, Iscovich J et al. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996; 65: 13 - 8.","DOI":"10.1016\/S0015-0282(16)58020-0"},{"key":"2934068_ref_34","doi-asserted-by":"crossref","unstructured":"Althuis MD, Moghissi KS, Westhoff CL et al. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 2005; 161: 607 - 15.","DOI":"10.1093\/aje\/kwi084"},{"key":"2934068_ref_35","doi-asserted-by":"crossref","unstructured":"Jensen A, Sharif H, Kjaer SK. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. Am J Epidemiol 2009; 170: 1408 - 14.","DOI":"10.1093\/aje\/kwp290"},{"key":"2934068_ref_36","doi-asserted-by":"crossref","unstructured":"Althuis MD, Scoccia B, Lamb EJ et al. Melanoma, thyroid, cervical, and colon cancer risk after use of\u00a0fertility drugs. Am J Obstet Gynecol 2005; 193: 668 - 74.","DOI":"10.1016\/j.ajog.2005.01.091"},{"key":"2934068_ref_37","unstructured":"Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update 2012; e-publisert 19.5.2012."},{"key":"2934068_ref_38","doi-asserted-by":"crossref","unstructured":"Tretli S, Magnus K. Height and weight in relation to uterine corpus cancer morbidity and mortality. A follow-up study of 570,000 women in Norway. Int J Cancer 1990; 46: 165 - 72.","DOI":"10.1002\/ijc.2910460204"},{"key":"2934068_ref_39","doi-asserted-by":"crossref","unstructured":"Pearce CL, Templeman C, Rossing MA et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13: 385 - 94.","DOI":"10.1016\/S1470-2045(11)70404-1"},{"key":"2934068_ref_40","first-page":"1789 - 99","volume":"364","author":"Giudice LC, Kao LC","year":"Lancet","journal-title":"40"},{"key":"2934068_ref_41","doi-asserted-by":"crossref","unstructured":"Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 2001; 7: 522 - 5.","DOI":"10.1093\/humupd\/7.6.522"},{"key":"2934068_ref_42","doi-asserted-by":"crossref","unstructured":"Levanon K, Crum C, Drapkin R. New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 2008; 26: 5284 - 93.","DOI":"10.1200\/JCO.2008.18.1107"},{"key":"2934068_ref_43","doi-asserted-by":"crossref","unstructured":"Manchanda R, Drapkin R, Jacobs I et al. The role of\u00a0peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian\/tubal cancer. Gynecol Oncol 2012; 124: 185 - 91.","DOI":"10.1016\/j.ygyno.2011.10.017"},{"key":"2934068_ref_44","doi-asserted-by":"crossref","unstructured":"Brinton LA, Moghissi KS, Scoccia B et al. Ovulation induction and cancer risk. Fertil Steril 2005; 83: 261 - 74.","DOI":"10.1016\/j.fertnstert.2004.09.016"},{"key":"2934068_ref_45","first-page":"163","volume":"2","author":"Fathalla MF","year":"Lancet","journal-title":"45"},{"key":"2934068_ref_46","first-page":"1250 - 4","volume":"344","author":"Adami HO, Hsieh CC, Lambe M et al","year":"Lancet","journal-title":"46"},{"key":"2934068_ref_47","first-page":"284 - 90","volume":"76","author":"Hankinson SE, Colditz GA, Hunter DJ et al","year":"Cancer","journal-title":"47"},{"key":"2934068_ref_48","doi-asserted-by":"crossref","unstructured":"Mosgaard BJ, Lidegaard O, Kjaer SK et al. Infertility, fertility drugs, and invasive ovarian cancer: a\u00a0case-control study. Fertil Steril 1997; 67: 1005 - 12.","DOI":"10.1016\/S0015-0282(97)81431-8"},{"key":"2934068_ref_49","doi-asserted-by":"crossref","unstructured":"Jensen A, Sharif H, Olsen JH et al. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women. Am J\u00a0Epidemiol 2008; 168: 49 - 57.","DOI":"10.1093\/aje\/kwn094"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T17:30:10Z","timestamp":1562607010000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2012\/11\/oversiktsartikkel\/infertilitetsbehandling-og-kreftrisiko"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":49,"journal-issue":{"issue":"22"},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.12.0376","relation":{},"ISSN":["0029-2001"],"issn-type":[{"value":"0029-2001","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}